期刊文献+

AZD5363诱导肝癌细胞凋亡与自噬的实验研究 被引量:5

Effect of AZD5363 on apoptosis and autophagy in hepatocellular carcinoma cells
下载PDF
导出
摘要 目的:研究新型Akt抑制剂AZD5363对人肝癌HepG2和Huh7细胞活力、凋亡和自噬的影响,并探讨其抗肿瘤活性的分子机制。方法:采用不同浓度AZD5363作用于体外培养的HepG2和Huh7细胞,MTT法检测细胞活力;TUNEL标记法检测肝癌细胞凋亡的变化;Western blot实验分析细胞凋亡相关蛋白多腺苷二磷酸核糖聚合酶[poly(ADP-ribose) polymerase,PARP]及自噬标志蛋白LC3-II的表达水平;细胞转染GFP-LC3绿色荧光蛋白融合表达质粒检测细胞自噬。结果:AZD5363能够剂量依赖性地抑制HepG2和Huh7细胞活力,并通过促进PARP的切割而诱导肝癌细胞发生凋亡;肝癌细胞给予AZD5363后,细胞内GFP-LC3融合蛋白斑点增多,同时LC3-II的表达水平增加(P <0.05);当用氯喹阻断自噬后,AZD5363对肝癌细胞凋亡的诱导作用明显增强。结论:AZD5363可促进HepG2和Huh7细胞发生凋亡和保护性自噬。抑制自噬促进了AZD5363诱导的肝癌细胞凋亡。 AIM:To investigate the effect of AZD5363,an inhibitor of Akt,on the viability,apoptosis and autophagy in human hepatocelluar carcinoma cells and the molecular mechanisms.METHODS:MTT assay was used to detect the cell viability.TUNEL assay was used to analysis the apoptosis.The expression of PARP and LC3-II proteins was examined by Western blot analysis.The autophagy was characterized by the expression and distribution of GFP-LC3.RESULTS:The results of MTT assay indicated that AZD5363 suppressed the cell viability in a dose-dependent manner(P<0.05).High doses of AZD5363 triggered apoptosis via activating the cleavage of PARP.AZD5363 treatment induced autophagy both in HepG2 cells and Huh7 cells by increasing the level of LC3-II.Blockage of autophagy by chloroquine promoted AZD5363-induced apoptosis in the hepatocellular carcinoma cells.CONCLUSION:AZD5363 increased apoptosis and autophagy in HepG2 cells and Huh7 cells.Blockage of autophagy magnified AZD5363-induced apoptosis in hepatocellular carcinoma cells.
作者 李若彤 LI Ruo-tong(Department of Pathology,Taian City Central Hospital,Taian 271000,China)
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2019年第2期280-285,共6页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.81703039)
关键词 肝细胞癌 AKT信号通路 AZD5363 细胞凋亡 自噬 Hepatocellular carcinoma Akt signaling pathway AZD5363 Apoptosis Autophagy
  • 引文网络
  • 相关文献

参考文献3

二级参考文献24

  • 1李文艳,朱珺.雷帕霉素对人非小细胞肺癌细胞株A549生长及增殖的影响[J].上海交通大学学报(医学版),2011,31(3):275-278. 被引量:1
  • 2Shackelford DB, Abt E, Gerken L, et al. LKB1 inactiva- tion dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin [ J ]. Cancer Cell, 2013, 23 (2) : 143-158.
  • 3Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gem- citabine versus gemcitabine for biliary tract cancer [ J ]. New Engl J Med, 2010, 362(14) : 1273-1281.
  • 4Tang CH, Parham C, Shocron E, et al. Picoplatin over- comes resistance to cell toxicity in small-cell lung cancer cells previously treated with eisplatin and earboplatin [ J ]. Cancer Chemother Pharmacol, 2011,67(6) :1389-1400.
  • 5Joshi M, Liu X, Belani CP. Taxanes, past, present, and future impact on non-small cell lung cancer [ J ]. Anti- cancer Drugs, 2014, 25(5) :571-583.
  • 6Gao Y, Baird AM, Barr M, et al. Epigenetic therapy for cisplatin resistance in non-small-cell lung cancer: the way forward? [J]. Lung Cancer Mgt, 2013, 2(1) :1-4.
  • 7Wang Q, Zhong M, Liu W, et al. Alterations of micro- RNAs in cisplatin-resistant human non-small cell lung cancer cells (A549/DDP) [ J ]. Exp Lung Res, 2011, 37 (7) :427-434.
  • 8Ramer R, Bublitz K, Freimuth N, et al. Cannabidiol in- hibits lung cancer cell invasion and metastasis via intercel- lular adhesion molecule-1 [J]. FASEB J, 2012, 26(4) : 1535-1548.
  • 9Yang X, Popescu NC, Zimonjie DB. DLC1 interaction with S100A10 mediates inhibition of in vitro cell invasion and tumorigenicity of lung cancer cells through a RhoGAP- independent mechanism[ J]. Cancer Res, 2011, 71 (8) : 2916-2925.
  • 10Chien ST, Lin SS, Wang CK, et al. Acaeetin inhibits the invasion and migration of human non-small cell lung cancer A549 cells by suppressing the p38a MAPK signa- ling pathway [ J ]. Mol Cell Biochem, 2011, 350 ( 1-2 ) : 135-148.

共引文献10

同被引文献31

引证文献5

二级引证文献19

;
使用帮助 返回顶部